Royal Marsden NHS Foundation Trust
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 109
- Registration Number
- NCT00220051
Prospective Study in Pelvic Radiotherapy Patients
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2005-09-22
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 100
- Registration Number
- NCT00220181
Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer
Not Applicable
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2015-11-25
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 400
- Registration Number
- NCT00220077
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2010-01-06
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 172
- Registration Number
- NCT00220116
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Neoadjuvant Epirubicin, Cisplatin and Capecitabine (ECX) Followed by Definitive Chemoradiation With/Without Surgery for Squamous Cell Carcinoma of the Oesophagus
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 16
- Registration Number
- NCT00220129
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 33
- Registration Number
- NCT00220168
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 16
- Registration Number
- NCT00220155
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer
Phase 2
- Conditions
- First Posted Date
- 2004-05-17
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 100
- Registration Number
- NCT00083018
- Locations
- π¬π§
Royal Marsden - London, London, England, United Kingdom
Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer
Phase 2
- Conditions
- First Posted Date
- 2004-05-17
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 60
- Registration Number
- NCT00082979
- Locations
- π¬π§
Royal Marsden - London, London, England, United Kingdom
Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer
Not Applicable
- Conditions
- First Posted Date
- 2004-04-19
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Registration Number
- NCT00005071
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, England, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath